(19)
(11) EP 4 377 313 A1

(12)

(43) Date of publication:
05.06.2024 Bulletin 2024/23

(21) Application number: 22754497.0

(22) Date of filing: 29.07.2022
(51) International Patent Classification (IPC): 
C07D 471/04(2006.01)
C07D 487/04(2006.01)
A61P 1/00(2006.01)
A61P 1/12(2006.01)
C07D 473/34(2006.01)
C07D 519/00(2006.01)
A61P 1/04(2006.01)
(52) Cooperative Patent Classification (CPC):
C07D 519/00; C07D 473/34; C07D 487/04; C07D 471/04; A61P 1/04; A61P 1/12; A61P 1/00
(86) International application number:
PCT/GB2022/052010
(87) International publication number:
WO 2023/007185 (02.02.2023 Gazette 2023/05)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 30.07.2021 GB 202111001

(71) Applicant: BenevolentAI Cambridge Limited
London W1T 5HD (GB)

(72) Inventors:
  • ALMOND-THYNNE, Joshua
    London W1T 5HD (GB)
  • PATIENT, Lee
    London W1T 5HD (GB)
  • BALMOND, Edward I.
    London W1T 5HD (GB)
  • ROBAS, Nicola
    London W1T 5HD (GB)
  • BELICH, Monica Polidoro
    London W1T 5HD (GB)

(74) Representative: Gill Jennings & Every LLP 
The Broadgate Tower 20 Primrose Street
London EC2A 2ES
London EC2A 2ES (GB)

   


(54) IMIDAZOLE ORGANIC COMPOUNDS AND THEIR USE AGAINST INFLAMMATORY BOWEL DISEASE